Filing Details
- Accession Number:
- 0001179110-13-004842
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-11 17:50:17
- Reporting Period:
- 2013-03-08
- Filing Date:
- 2013-03-11
- Accepted Time:
- 2013-03-11 17:50:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208907 | G Thomas Wiggans | C/O Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-08 | 2,000 | $27.63 | 10,065 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-08 | 2,000 | $85.00 | 8,065 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-08 | 2,000 | $0.00 | 2,000 | $27.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | 2007-03-09 | 2016-03-09 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
Billionaire Hedge Funds
